Importance of local aromatase activity in hormone-dependent breast cancer: a review
Open Access
- 1 April 2001
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 10 (2) , 91-99
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Survival advantage of exemestane (EXE, Aromasin®) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind studyEuropean Journal of Cancer, 1999
- Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)European Journal of Cancer, 1997
- A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *European Journal of Cancer, 1996
- Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancerPharmacogenetics, 1995
- On the significance of in situ production of oestrogens in human breast cancer tissueThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Concentrations of oestrone and 4‐hydroxyandrostenedione in malignant and normal breast tissuesInternational Journal of Cancer, 1991
- Properties of estrogen and hydroxysteroid sulphotransferases in human mammary cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Correlation of aromatase activity with histological differentiation of breast cancer — A morphometric analysisBreast Cancer Research and Treatment, 1988
- Metabolism of estradiol by human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- The role of tissue steroids in regulating aromatase and oestradiol 17β-hydroxysteroid dehydrogenase activities in breast and endometrial cancerJournal of Steroid Biochemistry, 1986